Summary
Trimethoprim enhances the in vitro activity of nalidixic and oxolinic acids against some representative pathogenic microorganisms, including those which are most frequently responsible for urinary tract infections, and delays the emergence of resistance in many of them.
Similar content being viewed by others
References
M. Buchbinder, J.C. Webb, L.V. Anderson and W.R. McCabe, Antimicrob. Agents Chemother.1962, 308 (1963).
J.T. Holland and J.Z. Montgomerie, New Zealand med. J.63, 498 (1964).
K.V. Parkkulainen and M. Jahkola, Nord. Med.74, 1231 (1965).
S.M. Finegold, L.G. Miller, D. Posnick, D.K. Patterson and A. Davis, Antimicrob. Agents Chemother.1966, 189 (1967).
E. Atlas, H. Clark, F. Silverblatt and M. Turck, Ann. int. Med.70, 713 (1969).
W.H. Deitz, J.H. Bailey and E.J. Froelich, Antimicrob. Agents Chemother.1963, 583 (1964).
R.P. Moungton and A. Koelman, Chemotherapia11, 10 (1966).
R. Auriti and L. Ravagnan, Antibiotica6, 72 (1968).
J.G. Baudens and Y.A. Chabbert, Path. Biol.17, 391 (1969).
J.D. Piquet, Ann. Inst. Pasteur116, 43 (1969).
J. Michel, R. Luboshitzky and T. Sacks, Antimicrob. Agents Chemother.4, 201 (1973).
E.F. Gale, E. Cundliffe, P.E. Reynolds, M.H. Richmond and M.J. Waring, The molecular basis of antibiotic action, p.36. John Wiley and Sons, London 1972.
W.A. Goss, W.H. Deitz and T.M. Cook, J. Bact.88, 1112 (1964).
W.A. Goss, W.H. Deitz and T.M. Cook, J. Bact.89, 1068 (1965).
R.G. Fenwick and R. Curtiss, J. Bact.116, 1236 (1973).
R.M. Weiner and M.A. Blackmann, J. Bact.116, 1398 (1973).
T.J. Simon, W.E. Masker and P.C. Hanavalt, Biochem. Biophys. Acta349/2, 271 (1974).
J.R.N. Bushby and G.H. Hitchings, Br. J. Pharmac. Chemother.33, 72 (1968).
G.H. Hitchings, Ann. N.Y. Acad. Sci.186, 444 (1971).
G.B. Elion, S. Singer and G.H. Hitchings J. biol. Chem.208, 477 (1954).
E.W. McChesney, E.J. Froelich, G.Y. Lesher, A.V.R. Crain and D. Rosi, Toxic. appl. Pharmac.6, 292 (1964).
S.M. Ringel, F.J. Turner, S. Roemer, J.M. Daly, R. Zlatanoff and B.S. Schwartz, Antimicrob. Agents Chemother.1967, 486 (1968).
D.E. Schwartz and J. Rieder, Chemotherapy15, 337 (1970).
K. Berneis and W. Boguth, Chemotherapy22, 390 (1976).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bertolini, A., Castelli, M., Genedani, S. et al. Trimethoprim enhances the antibacterial activity of nalidixic and oxolinic acids and delays the emergence of resistance. Experientia 36, 243–244 (1980). https://doi.org/10.1007/BF01953757
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01953757